Skip to content
Search

Latest Stories

iGAS: David Webb asks pharmacies to order antibiotics ‘sensibly’

With  higher than usual number of cases of scarlet fever, caused by invasive Group A streptococci (iGAS) infections being reported in children across the country, Chief Pharmaceutical Officer for England David Webb has assured pharmacies of sufficient supply of antibiotics.

In a letter, shared by the PDA, Webb also urged the pharmacies to order antibiotic stocks sensibly.


“Local pharmacy teams may be experiencing a temporary interruption of supply of some relevant antibiotics due to increased demand. On a national level, sufficient stock exists for the NHS,” he said.

He said NHS is working closely with the Department of Health and Social Care (DHSC) and has taken actions to help ensure medicines continue to be available.

He explained that the supplies of antibiotics for the treatment of Group A Strep, particularly phenoxymethylpenicillin presentations, have seen a surge in demand, leading to potential constraints at certain wholesalers and pharmacies,

“Supplies are readily available with manufacturers and deliveries into wholesalers and pharmacies are being expedited and are expected in the coming days,” he added.

Where antibiotic therapy is required for the treatment of suspected GAS infection, he asked prescribers and local pharmacy teams to “work together to understand availability of antibiotics locally and order antibiotic stocks sensibly, in line with patient demand,” ensuring that excessive quantities are not ordered to avoid more pressure on the supply chain.

He also urged pharmacy teams to reassure worried parents and carers, as well as patients, and display the guidance available at NHS website prominently on site.

In a statement today (9 December), the RPS has also noted that pharmacists and teams are working hard to resolve stock issues around antibiotics.

“The situation around rising cases of Strep A and obtaining antibiotics has been challenging for patients, parents and carers, pharmacists and all those in our health system working to help patients,” Professor Claire Anderson, RPS president, and Thorrun Govind, Andrew Carruthers and Cheryl Way, chairs of the body in England, Scotland and Wales respectively, said in a joint statement.

“Thank you to all pharmacists and pharmacy technicians working hard to resolve stock issues around antibiotics needed to treat Strep A. We know you’re under enormous pressure and doing everything you can to keep patients well. Your professionalism in the face of adversity and determination to put patients first is always inspiring but we recognize often comes at a personal cost to your wellbeing.

“We are in contact with the NHS and governments across Great Britain and doing all we can to support you to help patients. The situation is under constant review and the aim of everyone is to ensure patients get access to the medicines they need.”

Earlier, PSNC has said that its Dispensing and Supply Team has received reports from some contractors and pharmacy teams who are finding it difficult to obtain certain antibiotics.

“Pharmacy teams are reporting that there is little or no stock of liquid amoxicillin and phenoxymethylpenicillin (Pen V) showing at wholesalers, and that the supply challenges have now extended to other oral antibiotics too. PSNC is also monitoring prices for these medicines and is seeking concessionary prices based on reports received from contractors,” it said.

The Healthcare Distribution Association has confirmed that the huge spike in demand for several antibiotics, adding that its members are working hard with manufacturers to increase supply to meet this unprecedented demand.

On Wednesday, Alliance Healthcare issued the following update: “Working with the healthcare industry Alliance Healthcare works closely with manufacturers to ensure maximum supply of product to UK patients. Demand has been high across our antibiotics range recently and despite generally good supply levels, we are experiencing some short-term impact as a result, however more replenishment is on the way. We ask that our customers only buy what they need and continue to regularly check myahportal.co.uk for the most up to date stock availability information.”

Misinformation

Meanwhile, the PSNC has flagged some misinformation that has been spreading on social media about the help that community pharmacies can provide.

A suggestion has been made that pharmacies can test for strep A and hand out antibiotics, but this is not an NHS service and is only provided by a small number of pharmacies privately and under specific PGDs or where independent prescribers are available, it noted.

“PSNC is pushing DHSC and NHS England to address these misconceptions and put out clear communications on where parents should go for help and where pharmacy teams should direct people to,” the organization said.

PSNC asked pharmacies to make use of the social media resources developed by the UKHSA, available to download from the DHSC campaign resources center, to raise awareness amongst the public.

It also highlighted the guide published by the Specialist Pharmacy Service (SPS) on using solid oral dosage form antibiotics in children, including use for Group A streptococcal infections.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less